Vivoryon Therapeutics
Biopharmaceutical company focused on the development of innovative small molecule drugs.
Launch date
Employees
Market cap
$59.6m
Enterprise valuation
$28m (Public information from Sep 2024)
Share price
€2.135 VVY.AS
Halle (Saale) Saxony-Anhalt (HQ)
Authorizing premium user...